Back to top
more

Plexus (PLXS)

(Delayed Data from NSDQ)

$143.50 USD

143.50
185,930

-1.98 (-1.36%)

Updated Nov 6, 2025 04:00 PM ET

After-Market: $143.49 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.63%
2Buy17.80%
3Hold9.42%
4Sell5.10%
5Strong Sell2.04%
S&P50010.70%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (100 out of 252)

Industry: Electronics - Manufacturing Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Aniruddha Ganguly headshot

6 Tech Stocks That Have Crushed FAANG in 2019

by Aniruddha Ganguly

Here we pick six stocks that have outperformed the FAANG group on a year-to-date basis in 2019.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Ultra Clean Holdings, Plexus, Tennant, Cohu and Kaman

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Ultra Clean Holdings, Plexus, Tennant, Cohu and Kaman

Nalak Das headshot

5 Top-Ranked Manufacturing Stocks to Buy Amid Slowdown in 2019

by Nalak Das

Despite slowdown, a few manufacturing stocks popped in the past six months and still have upside left.

Zacks Equity Research

Plexus (PLXS) Up 7.6% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus

Nalak Das headshot

5 Top Momentum Stocks in October That Still Have Upside Left

by Nalak Das

Possibility of at least an interim trade deal between the largest trading countries of the world boosted investors' confidence on risky assets like equities.

Zacks Equity Research

Plexus Corp. (PLXS) Shares March Higher, Can It Continue?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Plexus Corp. (PLXS).

Zacks Equity Research

Zacks.com featured highlights include: Plexus, Costamare, United Therapeutics, Intel and First American Financial

by Zacks Equity Research

Zacks.com featured highlights include: Plexus, Costamare, United Therapeutics, Intel and First American Financial

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for October 30th

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 30th

Nilanjan Choudhury headshot

5 Solid Relative Price Strength Stocks to Make You Rich

by Nilanjan Choudhury

Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.

Zacks Equity Research

Plexus (PLXS) Q4 Earnings Beat Estimates, Revenues Up Y/Y

by Zacks Equity Research

Plexus' (PLXS) fourth-quarter results reflect robust revenues from Healthcare/Life Sciences, Industrial/Commercial and Aerospace/Defense sectors.

Zacks Equity Research

Plexus (PLXS) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Plexus (PLXS) delivered earnings and revenue surprises of 8.14% and 4.12%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Plexus (PLXS) Q4 Earnings Expected to Decline

by Zacks Equity Research

Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Plexus (PLXS) Down 0.2% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Plexus (PLXS) Q3 Earnings Miss Estimates, Revenues Up Y/Y

by Zacks Equity Research

Plexus' (PLXS) third-quarter results benefit from robust revenues from Healthcare/Life Sciences and Aerospace/Defense sectors despite unfavorable mix, which hurt margins.

Zacks Equity Research

Plexus (PLXS) Q3 Earnings Miss Estimates

by Zacks Equity Research

Plexus (PLXS) delivered earnings and revenue surprises of -1.22% and 2.49%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Plexus (PLXS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Plexus (PLXS) Down 6.9% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Plexus (PLXS) Q2 Earnings Miss Estimates, Revenues Beat

by Zacks Equity Research

Plexus (PLXS) second-quarter fiscal 2019 results benefit from strong performance of Healthcare/Life Sciences and Aerospace/Defense segments.

Zacks Equity Research

Plexus (PLXS) Q2 Earnings Miss Estimates

by Zacks Equity Research

Plexus (PLXS) delivered earnings and revenue surprises of -7.06% and 1.51%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Plexus (PLXS) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Why Is Plexus (PLXS) Up 10.1% Since Last Earnings Report?

by Zacks Equity Research

Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Plexus (PLXS) Beats Q1 Earnings Estimates, Revenues Up Y/Y

by Zacks Equity Research

Plexus' (PLXS) first-quarter fiscal 2019 results benefit from strong performance of the Healthcare/Life Sciences segment.

Zacks Equity Research

Plexus (PLXS) Tops Q1 Earnings Estimates

by Zacks Equity Research

Plexus (PLXS) delivered earnings and revenue surprises of 1.11% and -0.50%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Plexus (PLXS) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.